Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milnacipran in Fibromyalgia Syndrome (European Phase III)
NCT00436033Phase 3Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Feb 2006
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of milnacipran in fibromyalgia syndrome (FMS), sponsored by Pierre Fabre Laboratories. Started Feb 2006; status: completed.
02
Drugs
milnacipran
03
Conditions
fibromyalgia syndrome (FMS)
Beyond the preview
Go deeper on NCT00436033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00436033.